Exact Mass: 660.423711

Exact Mass Matches: 660.423711

Found 250 metabolites which its exact mass value is equals to given mass value 660.423711, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Croton factor F1

Hexadecanoic acid,(1S,1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-1,3-bis(hydroxymethyl)-1,6,8-trimethyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen

C38H60O9 (660.423711)


D009676 - Noxae > D002273 - Carcinogens > D010703 - Phorbol Esters

   

Tsugaric acid A 21-glucosyl ester

3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl 2-[5-(acetyloxy)-2,6,6,11,15-pentamethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-1(10)-en-14-yl]-6-methylhept-5-enoic acid

C38H60O9 (660.423711)


Tsugaric acid A 21-glucosyl ester is found in mushrooms. Tsugaric acid A 21-glucosyl ester is a constituent of Ganoderma tsugae (red reishi). Constituent of Ganoderma tsugae (red reishi). Tsugaric acid A 21-glucosyl ester is found in mushrooms.

   

PA(18:1(11Z)/15:0)

[(2R)-3-[(11Z)-octadec-11-enoyloxy]-2-(pentadecanoyloxy)propoxy]phosphonic acid

C36H69O8P (660.4729804)


PA(18:1(11Z)/15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(18:1(11Z)/15:0), in particular, consists of one chain of cis-vaccenic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(18:1(9Z)/15:0)

[(2R)-3-[(9Z)-octadec-9-enoyloxy]-2-(pentadecanoyloxy)propoxy]phosphonic acid

C36H69O8P (660.4729804)


PA(18:1(9Z)/15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(18:1(9Z)/15:0), in particular, consists of one chain of oleic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

26-Deoxyactein

4,5,6,12,17,17-Hexamethyl-18-[(3,4,5-trihydroxyoxan-2-yl)oxy]-3,6,9-trioxaspiro[bicyclo[3.1.0]hexane-2,8-hexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosane]-3-yl acetic acid

C37H56O10 (660.3873276)


   

PA(14:0/18:1(12Z)-O(9S,10R))

[(2R)-2-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]-3-(tetradecanoyloxy)propoxy]phosphonic acid

C35H65O9P (660.436597)


PA(14:0/18:1(12Z)-O(9S,10R)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(14:0/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one tetradecanoyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(18:1(12Z)-O(9S,10R)/14:0)

[(2R)-3-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]-2-(tetradecanoyloxy)propoxy]phosphonic acid

C35H65O9P (660.436597)


PA(18:1(12Z)-O(9S,10R)/14:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-O(9S,10R)/14:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of tetradecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(14:0/18:1(9Z)-O(12,13))

[(2R)-2-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}-3-(tetradecanoyloxy)propoxy]phosphonic acid

C35H65O9P (660.436597)


PA(14:0/18:1(9Z)-O(12,13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(14:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one tetradecanoyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(18:1(9Z)-O(12,13)/14:0)

[(2R)-3-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}-2-(tetradecanoyloxy)propoxy]phosphonic acid

C35H65O9P (660.436597)


PA(18:1(9Z)-O(12,13)/14:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(9Z)-O(12,13)/14:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of tetradecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(i-14:0/18:1(12Z)-O(9S,10R))

[(2R)-3-[(12-methyltridecanoyl)oxy]-2-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]propoxy]phosphonic acid

C35H65O9P (660.436597)


PA(i-14:0/18:1(12Z)-O(9S,10R)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(i-14:0/18:1(12Z)-O(9S,10R)), in particular, consists of one chain of one 12-methyltridecanoyl at the C-1 position and one chain of 9,10-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(18:1(12Z)-O(9S,10R)/i-14:0)

[(2R)-2-[(12-methyltridecanoyl)oxy]-3-[(8-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}octanoyl)oxy]propoxy]phosphonic acid

C35H65O9P (660.436597)


PA(18:1(12Z)-O(9S,10R)/i-14:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-O(9S,10R)/i-14:0), in particular, consists of one chain of one 9,10-epoxy-octadecenoyl at the C-1 position and one chain of 12-methyltridecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(i-14:0/18:1(9Z)-O(12,13))

[(2R)-3-[(12-methyltridecanoyl)oxy]-2-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propoxy]phosphonic acid

C35H65O9P (660.436597)


PA(i-14:0/18:1(9Z)-O(12,13)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(i-14:0/18:1(9Z)-O(12,13)), in particular, consists of one chain of one 12-methyltridecanoyl at the C-1 position and one chain of 12,13-epoxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(18:1(9Z)-O(12,13)/i-14:0)

[(2R)-2-[(12-methyltridecanoyl)oxy]-3-{[(9Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy}propoxy]phosphonic acid

C35H65O9P (660.436597)


PA(18:1(9Z)-O(12,13)/i-14:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(9Z)-O(12,13)/i-14:0), in particular, consists of one chain of one 12,13-epoxy-octadecenoyl at the C-1 position and one chain of 12-methyltridecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

26-Deoxyactein

[(1R,1R,3R,4S,4R,5R,5R,6R,10S,12S,13S,16R,18S,21R)-1,4,6,12,17,17-hexamethyl-18-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyspiro[3,6-dioxabicyclo[3.1.0]hexane-4,8-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosane]-3-yl] acetate

C37H56O10 (660.3873276)


26-Deoxyactein is a triterpenoid. It has a role as a metabolite. 26-Deoxyactein is a natural product found in Actaea elata, Actaea cimicifuga, and Actaea racemosa with data available. See also: Black Cohosh (part of). A natural product found in Actaea racemosa.

   

Gypsogenin-3-O-glucuronide

Methyl gypsogenin 3-O-beta-D-glucuronopyranoside;Gypsogenin 3-O-beta-D-glucuronopyranoside

C37H56O10 (660.3873276)


Gypsogenin-3-O-glucuronide is a ubiquitous saponin precursor in plants of the genus Gypsophila[1]. Gypsogenin-3-O-glucuronide is a ubiquitous saponin precursor in plants of the genus Gypsophila[1].

   
   

Cimiracemoside K

Cimiracemoside K

C37H56O10 (660.3873276)


A natural product found in Actaea racemosa.

   
   
   

25-O-acetyl-7,8-didehydrocimigenol 3-O-alpha-L-arabinopyranoside

25-O-acetyl-7,8-didehydrocimigenol 3-O-alpha-L-arabinopyranoside

C37H56O10 (660.3873276)


   

Antibiotic S 39163F1|S39163/F-I

Antibiotic S 39163F1|S39163/F-I

C38H60O9 (660.423711)


   
   
   

11alpha,12alpha-epoxy-3beta-[(O-beta-D-glucuronopyranoside-6-O-methly ester)oxy]olean-28,13-olide|gardeniside A

11alpha,12alpha-epoxy-3beta-[(O-beta-D-glucuronopyranoside-6-O-methly ester)oxy]olean-28,13-olide|gardeniside A

C37H56O10 (660.3873276)


   

saccharolidin A

saccharolidin A

C38H60O9 (660.423711)


   

4-apo-beta-caroten-4-oic acid beta-D-glucopyranoside|neurosporaxanthin beta-D-glucopyranoside

4-apo-beta-caroten-4-oic acid beta-D-glucopyranoside|neurosporaxanthin beta-D-glucopyranoside

C41H56O7 (660.4025826)


   

3-Epiwightiaol A tetraacetate

3-Epiwightiaol A tetraacetate

C38H60O9 (660.423711)


   

3-O-(3-Acetyl-beta-D-xylopyranoside)--16,23:16,24-Diepoxycycloart-7-ene-3,15,25-triol

3-O-(3-Acetyl-beta-D-xylopyranoside)--16,23:16,24-Diepoxycycloart-7-ene-3,15,25-triol

C37H56O10 (660.3873276)


   
   

23-epi-26-Deoxyactein

(1R,2R,2aR,4S,5R,6aR,7aR,9R,9aR,9bR,10R,13aS,14aS,14bS)-3,3,5,9a,10,14a-Hexamethyl-4-(((2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)oxy)octadecahydro-3,6-dioxaspiro[bicyclo[3.1.0]hexane-2,12-cyclopropa[1,8a]naphtho[2,1:4,5]indeno[2,1-b]pyran]-9-yl acetate

C37H56O10 (660.3873276)


23-epi-26-deoxyactein is a triterpenoid. It has a role as a metabolite. 23-EPI-26-Deoxyactein is a natural product found in Actaea racemosa with data available. See also: Black Cohosh (part of). A natural product found in Actaea racemosa. 23-epi-26-Deoxyactein is a natural and orally active anti-obesity and anti-cancer compound[1][2][3].

   

25-O-acetyl-7,8-didehydro-cimigenol-3-O-b-Dxylopyaranoside

25-O-acetyl-7,8-didehydro-cimigenol-3-O-b-Dxylopyaranoside

C37H56O10 (660.3873276)


   

C37H56O10_(2S,4aR,5aR,7R,7aR,8R,12aS,12bS,14aR)-1,1,5,7a,8,12a-Hexamethyl-2-(D-xylopyranosyloxy)hexadecahydro-2H-spiro[cyclopropa[1,8a]naphtho[2,1:4,5]indeno[2,1-b]pyran-10,2-[3,6]dioxabicyclo[3.1.0]hexan]-7-yl acetate

NCGC00385389-01_C37H56O10_(2S,4aR,5aR,7R,7aR,8R,12aS,12bS,14aR)-1,1,5,7a,8,12a-Hexamethyl-2-(D-xylopyranosyloxy)hexadecahydro-2H-spiro[cyclopropa[1,8a]naphtho[2,1:4,5]indeno[2,1-b]pyran-10,2-[3,6]dioxabicyclo[3.1.0]hexan]-7-yl acetate

C37H56O10 (660.3873276)


   

Neurosporaxanthin β-D-glucopyranoside

Neurosporaxanthin β-D-glucopyranoside

C41H56O7 (660.4025826)


   

Carbaprostacyclin-biotin

N-6,9α-methylene-11α,15S-dihydroxy-prosta-5E,13E-dien-1-oyl-N-biotinoyl-1,5-diaminopentane

C36H60N4O5S (660.428419)


   

PA(13:0/20:1(11Z))

1-tridecanoyl-2-(11Z-eicosenoyl)-glycero-3-phosphate

C36H69O8P (660.4729804)


   

PA(14:0/19:1(9Z))

1-tetradecanoyl-2-(9Z-nonadecenoyl)-glycero-3-phosphate

C36H69O8P (660.4729804)


   

PA(14:1(9Z)/19:0)

1-(9Z-tetradecenoyl)-2-nonadecanoyl-glycero-3-phosphate

C36H69O8P (660.4729804)


   

PA(15:0/18:1(9Z))

1-pentadecanoyl-2-(9Z-octadecenoyl)-glycero-3-phosphate

C36H69O8P (660.4729804)


   

PA(15:1(9Z)/18:0)

1-(9Z-pentadecenoyl)-2-octadecanoyl-glycero-3-phosphate

C36H69O8P (660.4729804)


   

PA(16:1(9Z)/17:0)

1-(9Z-hexadecenoyl)-2-heptadecanoyl-glycero-3-phosphate

C36H69O8P (660.4729804)


   

PA(17:0/16:1(9Z))

1-heptadecanoyl-2-(9Z-hexadecenoyl)-glycero-3-phosphate

C36H69O8P (660.4729804)


   

PA(17:1(9Z)/16:0)

1-(9Z-heptadecenoyl)-2-hexadecanoyl-glycero-3-phosphate

C36H69O8P (660.4729804)


   

PA(18:0/15:1(9Z))

1-octadecanoyl-2-(9Z-pentadecenoyl)-glycero-3-phosphate

C36H69O8P (660.4729804)


   

PA(18:1(9Z)/15:0)

1-(9Z-octadecenoyl)-2-pentadecanoyl-glycero-3-phosphate

C36H69O8P (660.4729804)


   

PA(19:0/14:1(9Z))

1-nonadecanoyl-2-(9Z-tetradecenoyl)-glycero-3-phosphate

C36H69O8P (660.4729804)


   

PA(19:1(9Z)/14:0)

1-(9Z-nonadecenoyl)-2-tetradecanoyl-glycero-3-phosphate

C36H69O8P (660.4729804)


   

PA(20:1(11Z)/13:0)

1-(11Z-eicosenoyl)-2-tridecanoyl-glycero-3-phosphate

C36H69O8P (660.4729804)


   

PA(16:0/17:1(9Z))

1-hexadecanoyl-2-(9Z-heptadecenoyl)-glycero-3-phosphate

C36H69O8P (660.4729804)


   

Tsugaric acid A 21-glucosyl ester

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 2-[5-(acetyloxy)-2,6,6,11,15-pentamethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-1(10)-en-14-yl]-6-methylhept-5-enoate

C38H60O9 (660.423711)


   

PA 33:1

1-hexadecanoyl-2-(9Z-heptadecenoyl)-glycero-3-phosphate

C36H69O8P (660.4729804)


   

Neurosporaxanthin beta-D-glucopyranoside

Neurosporaxanthin beta-D-glucopyranoside

C41H56O7 (660.4025826)


D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

   

2-(1,1-Dimethylethyl)-6-methyl-4-[3-[[2,4,8,10-tetrakis(1,1-dimethyleth yl)dibenzo[d,f][1,3,2]dioxaphosphepin-6-yl]oxy]propyl] phenol

2-(1,1-Dimethylethyl)-6-methyl-4-[3-[[2,4,8,10-tetrakis(1,1-dimethyleth yl)dibenzo[d,f][1,3,2]dioxaphosphepin-6-yl]oxy]propyl] phenol

C42H61O4P (660.4307236)


   

29-(nonylphenoxy)-3,6,9,12,15,18,21,24,27-nonaoxanonacosanol

29-(nonylphenoxy)-3,6,9,12,15,18,21,24,27-nonaoxanonacosanol

C35H64O11 (660.4448394)


   

PA(14:0/18:1(12Z)-O(9S,10R))

PA(14:0/18:1(12Z)-O(9S,10R))

C35H65O9P (660.436597)


   

PA(18:1(12Z)-O(9S,10R)/14:0)

PA(18:1(12Z)-O(9S,10R)/14:0)

C35H65O9P (660.436597)


   

PA(i-14:0/18:1(12Z)-O(9S,10R))

PA(i-14:0/18:1(12Z)-O(9S,10R))

C35H65O9P (660.436597)


   

PA(18:1(12Z)-O(9S,10R)/i-14:0)

PA(18:1(12Z)-O(9S,10R)/i-14:0)

C35H65O9P (660.436597)


   

PA(i-14:0/18:1(9Z)-O(12,13))

PA(i-14:0/18:1(9Z)-O(12,13))

C35H65O9P (660.436597)


   

PA(18:1(9Z)-O(12,13)/i-14:0)

PA(18:1(9Z)-O(12,13)/i-14:0)

C35H65O9P (660.436597)


   

[(2R)-2-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy-3-phosphonooxypropyl] tetradecanoate

[(2R)-2-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy-3-phosphonooxypropyl] tetradecanoate

C35H65O9P (660.436597)


   

[(2R)-1-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] tetradecanoate

[(2R)-1-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] tetradecanoate

C35H65O9P (660.436597)


   

1-Heptadecanoyl-2-palmitoyl-sn-glycero-3-phosphate(2-)

1-Heptadecanoyl-2-palmitoyl-sn-glycero-3-phosphate(2-)

C36H69O8P-2 (660.4729804)


   
   

[(1R,3R,4R,6R,12S,13S,16R,18S,21R)-1,4,6,12,17,17-hexamethyl-18-[(3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyspiro[3,6-dioxabicyclo[3.1.0]hexane-4,8-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosane]-3-yl] acetate

[(1R,3R,4R,6R,12S,13S,16R,18S,21R)-1,4,6,12,17,17-hexamethyl-18-[(3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyspiro[3,6-dioxabicyclo[3.1.0]hexane-4,8-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosane]-3-yl] acetate

C37H56O10 (660.3873276)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Mgdg O-26:7_3:0

Mgdg O-26:7_3:0

C38H60O9 (660.423711)


   
   
   
   

[(2R)-1-pentadecanoyloxy-3-phosphonooxypropan-2-yl] (Z)-16,16,17,17,18,18,18-heptadeuteriooctadec-9-enoate

[(2R)-1-pentadecanoyloxy-3-phosphonooxypropan-2-yl] (Z)-16,16,17,17,18,18,18-heptadeuteriooctadec-9-enoate

C36H69O8P (660.4729804)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C35H65O9P (660.436597)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C35H65O9P (660.436597)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propan-2-yl] tridecanoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propan-2-yl] tridecanoate

C35H65O9P (660.436597)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] undecanoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] undecanoate

C35H65O9P (660.436597)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C35H65O9P (660.436597)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propan-2-yl] (Z)-tridec-9-enoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-[(9Z,12Z)-hexadeca-9,12-dienoxy]propan-2-yl] (Z)-tridec-9-enoate

C35H65O9P (660.436597)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

6-[2,3-Di(tridecanoyloxy)propoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[2,3-Di(tridecanoyloxy)propoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid

C35H64O11 (660.4448394)


   

6-(2-Dodecanoyloxy-3-tetradecanoyloxypropoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

6-(2-Dodecanoyloxy-3-tetradecanoyloxypropoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid

C35H64O11 (660.4448394)


   

[(4E,8E,12E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]tetradeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

[(4E,8E,12E)-3-hydroxy-2-[[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]amino]tetradeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C37H61N2O6P (660.4267015999999)


   

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

[1-hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C34H61O10P (660.4002135999999)


   

[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C34H61O10P (660.4002135999999)


   

[1-[(2-decanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

[1-[(2-decanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C34H61O10P (660.4002135999999)


   

[1-[(2-dodecanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

[1-[(2-dodecanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C34H61O10P (660.4002135999999)


   

(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (Z)-tetracos-13-enoate

(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (Z)-tetracos-13-enoate

C36H69O8P (660.4729804)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C34H61O10P (660.4002135999999)


   

(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (Z)-hexacos-15-enoate

(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (Z)-hexacos-15-enoate

C36H69O8P (660.4729804)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C34H61O10P (660.4002135999999)


   

[2-[(Z)-pentadec-9-enoyl]oxy-3-phosphonooxypropyl] octadecanoate

[2-[(Z)-pentadec-9-enoyl]oxy-3-phosphonooxypropyl] octadecanoate

C36H69O8P (660.4729804)


   

[2-[(Z)-hexadec-9-enoyl]oxy-3-phosphonooxypropyl] heptadecanoate

[2-[(Z)-hexadec-9-enoyl]oxy-3-phosphonooxypropyl] heptadecanoate

C36H69O8P (660.4729804)


   

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C34H61O10P (660.4002135999999)


   

[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-phosphonooxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

[1-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-phosphonooxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C37H57O8P (660.3790852)


   

(1-phosphonooxy-3-tridecanoyloxypropan-2-yl) (Z)-icos-11-enoate

(1-phosphonooxy-3-tridecanoyloxypropan-2-yl) (Z)-icos-11-enoate

C36H69O8P (660.4729804)


   

[3-phosphonooxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] nonadecanoate

[3-phosphonooxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] nonadecanoate

C36H69O8P (660.4729804)


   

[1-decanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

[1-decanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C34H61O10P (660.4002135999999)


   

(1-pentadecanoyloxy-3-phosphonooxypropan-2-yl) (Z)-octadec-9-enoate

(1-pentadecanoyloxy-3-phosphonooxypropan-2-yl) (Z)-octadec-9-enoate

C36H69O8P (660.4729804)


   

(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (Z)-docos-13-enoate

(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (Z)-docos-13-enoate

C36H69O8P (660.4729804)


   

[3-phosphonooxy-2-[(Z)-tridec-9-enoyl]oxypropyl] icosanoate

[3-phosphonooxy-2-[(Z)-tridec-9-enoyl]oxypropyl] icosanoate

C36H69O8P (660.4729804)


   

(1-phosphonooxy-3-tetradecanoyloxypropan-2-yl) (Z)-nonadec-9-enoate

(1-phosphonooxy-3-tetradecanoyloxypropan-2-yl) (Z)-nonadec-9-enoate

C36H69O8P (660.4729804)


   

(1-dodecanoyloxy-3-phosphonooxypropan-2-yl) (Z)-henicos-11-enoate

(1-dodecanoyloxy-3-phosphonooxypropan-2-yl) (Z)-henicos-11-enoate

C36H69O8P (660.4729804)


   

(1-hexadecanoyloxy-3-phosphonooxypropan-2-yl) (Z)-heptadec-9-enoate

(1-hexadecanoyloxy-3-phosphonooxypropan-2-yl) (Z)-heptadec-9-enoate

C36H69O8P (660.4729804)


   

[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-phosphonooxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-phosphonooxypropan-2-yl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C37H57O8P (660.3790852)


   

[(2R)-2-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropyl] octadecanoate

[(2R)-2-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropyl] octadecanoate

C36H69O8P (660.4729804)


   

[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (E)-icos-13-enoate

[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (E)-icos-13-enoate

C36H69O8P (660.4729804)


   

[1-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

[1-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C37H56O10 (660.3873276)


   

[(2R)-1-pentadecanoyloxy-3-phosphonooxypropan-2-yl] (E)-octadec-13-enoate

[(2R)-1-pentadecanoyloxy-3-phosphonooxypropan-2-yl] (E)-octadec-13-enoate

C36H69O8P (660.4729804)


   

[(2R)-1-[(E)-hexadec-7-enoyl]oxy-3-phosphonooxypropan-2-yl] heptadecanoate

[(2R)-1-[(E)-hexadec-7-enoyl]oxy-3-phosphonooxypropan-2-yl] heptadecanoate

C36H69O8P (660.4729804)


   

2-[[2-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-undecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-undecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H67NO8P+ (660.4604052)


   

[(2R)-2-pentadecanoyloxy-3-phosphonooxypropyl] (E)-octadec-4-enoate

[(2R)-2-pentadecanoyloxy-3-phosphonooxypropyl] (E)-octadec-4-enoate

C36H69O8P (660.4729804)


   

[(2R)-2-[(E)-hexadec-9-enoyl]oxy-3-phosphonooxypropyl] heptadecanoate

[(2R)-2-[(E)-hexadec-9-enoyl]oxy-3-phosphonooxypropyl] heptadecanoate

C36H69O8P (660.4729804)


   

[(2R)-2-pentadecanoyloxy-3-phosphonooxypropyl] (E)-octadec-9-enoate

[(2R)-2-pentadecanoyloxy-3-phosphonooxypropyl] (E)-octadec-9-enoate

C36H69O8P (660.4729804)


   

[(2R)-2-pentadecanoyloxy-3-phosphonooxypropyl] (E)-octadec-13-enoate

[(2R)-2-pentadecanoyloxy-3-phosphonooxypropyl] (E)-octadec-13-enoate

C36H69O8P (660.4729804)


   

[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (E)-icos-11-enoate

[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (E)-icos-11-enoate

C36H69O8P (660.4729804)


   

[(2R)-1-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] octadecanoate

[(2R)-1-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] octadecanoate

C36H69O8P (660.4729804)


   

[(2R)-2-hexadecanoyloxy-3-phosphonooxypropyl] (E)-heptadec-9-enoate

[(2R)-2-hexadecanoyloxy-3-phosphonooxypropyl] (E)-heptadec-9-enoate

C36H69O8P (660.4729804)


   

[(2R)-3-phosphonooxy-2-[(E)-tetradec-9-enoyl]oxypropyl] nonadecanoate

[(2R)-3-phosphonooxy-2-[(E)-tetradec-9-enoyl]oxypropyl] nonadecanoate

C36H69O8P (660.4729804)


   

[(2R)-1-pentadecanoyloxy-3-phosphonooxypropan-2-yl] (E)-octadec-4-enoate

[(2R)-1-pentadecanoyloxy-3-phosphonooxypropan-2-yl] (E)-octadec-4-enoate

C36H69O8P (660.4729804)


   

[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (E)-icos-11-enoate

[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (E)-icos-11-enoate

C36H69O8P (660.4729804)


   

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (E)-docos-13-enoate

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (E)-docos-13-enoate

C36H69O8P (660.4729804)


   

[(2R)-1-decanoyloxy-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropan-2-yl] (9E,12E,15E)-octadeca-9,12,15-trienoate

[(2R)-1-decanoyloxy-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropan-2-yl] (9E,12E,15E)-octadeca-9,12,15-trienoate

C34H61O10P (660.4002135999999)


   

2-[[(2R)-3-decanoyloxy-2-[(9E,12E)-heptadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2R)-3-decanoyloxy-2-[(9E,12E)-heptadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H67NO8P+ (660.4604052)


   

[(2R)-1-[(E)-hexadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] heptadecanoate

[(2R)-1-[(E)-hexadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] heptadecanoate

C36H69O8P (660.4729804)


   

[(2R)-1-pentadecanoyloxy-3-phosphonooxypropan-2-yl] (E)-octadec-9-enoate

[(2R)-1-pentadecanoyloxy-3-phosphonooxypropan-2-yl] (E)-octadec-9-enoate

C36H69O8P (660.4729804)


   

[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-phosphonooxypropyl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

[2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxy-3-phosphonooxypropyl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

C37H57O8P (660.3790852)


   

[1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-[(E)-dodec-5-enoyl]oxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

[1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-[(E)-dodec-5-enoyl]oxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

C34H61O10P (660.4002135999999)


   

[(2R)-1-pentadecanoyloxy-3-phosphonooxypropan-2-yl] octadec-17-enoate

[(2R)-1-pentadecanoyloxy-3-phosphonooxypropan-2-yl] octadec-17-enoate

C36H69O8P (660.4729804)


   

[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (E)-icos-13-enoate

[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (E)-icos-13-enoate

C36H69O8P (660.4729804)


   

[(2R)-1-pentadecanoyloxy-3-phosphonooxypropan-2-yl] (E)-octadec-7-enoate

[(2R)-1-pentadecanoyloxy-3-phosphonooxypropan-2-yl] (E)-octadec-7-enoate

C36H69O8P (660.4729804)


   

[(2R)-1-phosphonooxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] nonadecanoate

[(2R)-1-phosphonooxy-3-[(E)-tetradec-9-enoyl]oxypropan-2-yl] nonadecanoate

C36H69O8P (660.4729804)


   

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-phosphonooxypropyl] (11E,13E,15E)-octadeca-11,13,15-trienoate

[2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxy-3-phosphonooxypropyl] (11E,13E,15E)-octadeca-11,13,15-trienoate

C37H57O8P (660.3790852)


   

[(2R)-2-pentadecanoyloxy-3-phosphonooxypropyl] (E)-octadec-7-enoate

[(2R)-2-pentadecanoyloxy-3-phosphonooxypropyl] (E)-octadec-7-enoate

C36H69O8P (660.4729804)


   

[1-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

[1-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

C37H56O10 (660.3873276)


   

[1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate

[1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-dodecanoyloxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate

C34H61O10P (660.4002135999999)


   

[(2R)-1-pentadecanoyloxy-3-phosphonooxypropan-2-yl] (E)-octadec-6-enoate

[(2R)-1-pentadecanoyloxy-3-phosphonooxypropan-2-yl] (E)-octadec-6-enoate

C36H69O8P (660.4729804)


   

[(2R)-2-pentadecanoyloxy-3-phosphonooxypropyl] octadec-17-enoate

[(2R)-2-pentadecanoyloxy-3-phosphonooxypropyl] octadec-17-enoate

C36H69O8P (660.4729804)


   

[(2R)-2-pentadecanoyloxy-3-phosphonooxypropyl] (E)-octadec-11-enoate

[(2R)-2-pentadecanoyloxy-3-phosphonooxypropyl] (E)-octadec-11-enoate

C36H69O8P (660.4729804)


   

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (E)-docos-13-enoate

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (E)-docos-13-enoate

C36H69O8P (660.4729804)


   

2-[[(2S)-2-decanoyloxy-3-[(9E,12E)-heptadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(2S)-2-decanoyloxy-3-[(9E,12E)-heptadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H67NO8P+ (660.4604052)


   

[(2R)-1-pentadecanoyloxy-3-phosphonooxypropan-2-yl] (E)-octadec-11-enoate

[(2R)-1-pentadecanoyloxy-3-phosphonooxypropan-2-yl] (E)-octadec-11-enoate

C36H69O8P (660.4729804)


   

[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-phosphonooxypropyl] (7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoate

[2-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-phosphonooxypropyl] (7E,9E,11E,13E,15E)-octadeca-7,9,11,13,15-pentaenoate

C37H57O8P (660.3790852)


   

[(2R)-1-decanoyloxy-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropan-2-yl] (6E,9E,12E)-octadeca-6,9,12-trienoate

[(2R)-1-decanoyloxy-3-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropan-2-yl] (6E,9E,12E)-octadeca-6,9,12-trienoate

C34H61O10P (660.4002135999999)


   

[(2S)-2-decanoyloxy-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropyl] (6E,9E,12E)-octadeca-6,9,12-trienoate

[(2S)-2-decanoyloxy-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropyl] (6E,9E,12E)-octadeca-6,9,12-trienoate

C34H61O10P (660.4002135999999)


   

[(2R)-2-[(E)-hexadec-7-enoyl]oxy-3-phosphonooxypropyl] heptadecanoate

[(2R)-2-[(E)-hexadec-7-enoyl]oxy-3-phosphonooxypropyl] heptadecanoate

C36H69O8P (660.4729804)


   

[(2R)-2-pentadecanoyloxy-3-phosphonooxypropyl] (E)-octadec-6-enoate

[(2R)-2-pentadecanoyloxy-3-phosphonooxypropyl] (E)-octadec-6-enoate

C36H69O8P (660.4729804)


   

[(2S)-2-decanoyloxy-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropyl] (9E,12E,15E)-octadeca-9,12,15-trienoate

[(2S)-2-decanoyloxy-3-[[(2R)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxypropyl] (9E,12E,15E)-octadeca-9,12,15-trienoate

C34H61O10P (660.4002135999999)


   

[(2R)-1-hexadecanoyloxy-3-phosphonooxypropan-2-yl] (E)-heptadec-9-enoate

[(2R)-1-hexadecanoyloxy-3-phosphonooxypropan-2-yl] (E)-heptadec-9-enoate

C36H69O8P (660.4729804)


   

2-[[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-undecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-undecanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H67NO8P+ (660.4604052)


   

2-[hydroxy-[2-[(Z)-tetradec-9-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-[(Z)-tetradec-9-enoyl]oxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C35H67NO8P+ (660.4604052)


   

2-[hydroxy-[3-nonanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-nonanoyloxy-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C35H67NO8P+ (660.4604052)


   

2-[[3-decanoyloxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-decanoyloxy-2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H67NO8P+ (660.4604052)


   

2-[[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[(11Z,14Z)-henicosa-11,14-dienoyl]oxy-3-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H67NO8P+ (660.4604052)


   

2-[[3-heptanoyloxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[3-heptanoyloxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H67NO8P+ (660.4604052)


   

2-[hydroxy-[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-octanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxy-3-octanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C35H67NO8P+ (660.4604052)


   

2-[[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[2-[(13Z,16Z)-docosa-13,16-dienoyl]oxy-3-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C35H67NO8P+ (660.4604052)


   

2-[hydroxy-[3-propanoyloxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[3-propanoyloxy-2-[(13Z,16Z)-tetracosa-13,16-dienoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C35H67NO8P+ (660.4604052)


   

1-(9Z-octadecenoyl)-2-pentadecanoyl-glycero-3-phosphate

1-(9Z-octadecenoyl)-2-pentadecanoyl-glycero-3-phosphate

C36H69O8P (660.4729804)


   

1-Heptadecanoyl-2-palmitoyl-sn-glycero-3-phosphate(2-)

1-Heptadecanoyl-2-palmitoyl-sn-glycero-3-phosphate(2-)

C36H69O8P (660.4729804)


A 1,2-diacyl-sn-glycerol 3-phosphate(2-) in which the phosphatidyl acyl groups at postions 1 and 2 are specified as heptadecanoyl and palmitoyl respectively.

   

1-(9Z-tetradecenoyl)-2-nonadecanoyl-glycero-3-phosphate

1-(9Z-tetradecenoyl)-2-nonadecanoyl-glycero-3-phosphate

C36H69O8P (660.4729804)


   

1-(9Z-hexadecenoyl)-2-heptadecanoyl-glycero-3-phosphate

1-(9Z-hexadecenoyl)-2-heptadecanoyl-glycero-3-phosphate

C36H69O8P (660.4729804)


   

1-heptadecanoyl-2-(9Z-hexadecenoyl)-glycero-3-phosphate

1-heptadecanoyl-2-(9Z-hexadecenoyl)-glycero-3-phosphate

C36H69O8P (660.4729804)


   

1-(9Z-nonadecenoyl)-2-tetradecanoyl-glycero-3-phosphate

1-(9Z-nonadecenoyl)-2-tetradecanoyl-glycero-3-phosphate

C36H69O8P (660.4729804)


   

1-tetradecanoyl-2-(9Z-nonadecenoyl)-glycero-3-phosphate

1-tetradecanoyl-2-(9Z-nonadecenoyl)-glycero-3-phosphate

C36H69O8P (660.4729804)


   

1-pentadecanoyl-2-(9Z-octadecenoyl)-glycero-3-phosphate

1-pentadecanoyl-2-(9Z-octadecenoyl)-glycero-3-phosphate

C36H69O8P (660.4729804)


   

1-(9Z-pentadecenoyl)-2-octadecanoyl-glycero-3-phosphate

1-(9Z-pentadecenoyl)-2-octadecanoyl-glycero-3-phosphate

C36H69O8P (660.4729804)


   

1-(9Z-heptadecenoyl)-2-hexadecanoyl-glycero-3-phosphate

1-(9Z-heptadecenoyl)-2-hexadecanoyl-glycero-3-phosphate

C36H69O8P (660.4729804)


   

1-octadecanoyl-2-(9Z-pentadecenoyl)-glycero-3-phosphate

1-octadecanoyl-2-(9Z-pentadecenoyl)-glycero-3-phosphate

C36H69O8P (660.4729804)


   

1-nonadecanoyl-2-(9Z-tetradecenoyl)-glycero-3-phosphate

1-nonadecanoyl-2-(9Z-tetradecenoyl)-glycero-3-phosphate

C36H69O8P (660.4729804)


   

1-hexadecanoyl-2-(9Z-heptadecenoyl)-glycero-3-phosphate

1-hexadecanoyl-2-(9Z-heptadecenoyl)-glycero-3-phosphate

C36H69O8P (660.4729804)


   

1-tridecanoyl-2-(11Z-eicosenoyl)-glycero-3-phosphate

1-tridecanoyl-2-(11Z-eicosenoyl)-glycero-3-phosphate

C36H69O8P (660.4729804)


   

1-(11Z-eicosenoyl)-2-tridecanoyl-glycero-3-phosphate

1-(11Z-eicosenoyl)-2-tridecanoyl-glycero-3-phosphate

C36H69O8P (660.4729804)


   

1-oleoyl-2-pentadecanoyl-sn-glycero-3-phosphate

1-oleoyl-2-pentadecanoyl-sn-glycero-3-phosphate

C36H69O8P (660.4729804)


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl substituents at positions 1 and 2 are specified as oleoyl and pentadecanoyl respectively.

   

TG(39:10)

TG(18:4_10:2_11:4)

C42H60O6 (660.4389659999999)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

PMe(32:1)

PMe(16:0_16:1)

C36H69O8P (660.4729804)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

BisMePA(31:1)

BisMePA(15:0_16:1)

C36H69O8P (660.4729804)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   
   
   
   
   
   

PA O-20:0/12:3;O2

PA O-20:0/12:3;O2

C35H65O9P (660.436597)


   
   
   
   

PA P-20:0/12:2;O2

PA P-20:0/12:2;O2

C35H65O9P (660.436597)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(2s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2e,4e,6e,8e,10e,12e,14e,16e,18e,20e)-2,6,10,15,19-pentamethyl-21-(2,6,6-trimethylcyclohex-1-en-1-yl)henicosa-2,4,6,8,10,12,14,16,18,20-decaenoate

(2s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2e,4e,6e,8e,10e,12e,14e,16e,18e,20e)-2,6,10,15,19-pentamethyl-21-(2,6,6-trimethylcyclohex-1-en-1-yl)henicosa-2,4,6,8,10,12,14,16,18,20-decaenoate

C41H56O7 (660.4025826)


   

(2e)-4-{[(1s,2r,4s,7z,10r,11r)-4-(hydroxymethyl)-8-methyl-12-methylidene-13-oxo-3,14-dioxatricyclo[9.3.0.0²,⁴]tetradec-7-en-10-yl]oxy}-3-methyl-4-oxobut-2-en-1-yl (3s)-3-hydroxyoctadecanoate

(2e)-4-{[(1s,2r,4s,7z,10r,11r)-4-(hydroxymethyl)-8-methyl-12-methylidene-13-oxo-3,14-dioxatricyclo[9.3.0.0²,⁴]tetradec-7-en-10-yl]oxy}-3-methyl-4-oxobut-2-en-1-yl (3s)-3-hydroxyoctadecanoate

C38H60O9 (660.423711)


   

8-(3,9-dihydroxy-4,8-dimethyl-5-oxodec-6-en-2-yl)-20-hydroxy-9-methoxy-1,3,13-trimethyl-16-pentyl-7,17,19-trioxabicyclo[13.4.1]icosa-2,4,10,12-tetraen-6-one

8-(3,9-dihydroxy-4,8-dimethyl-5-oxodec-6-en-2-yl)-20-hydroxy-9-methoxy-1,3,13-trimethyl-16-pentyl-7,17,19-trioxabicyclo[13.4.1]icosa-2,4,10,12-tetraen-6-one

C38H60O9 (660.423711)


   

2-hydroxy-3,8,8,17,19-pentamethyl-22-(prop-1-en-2-yl)-9-[(3,4,5-trihydroxyoxan-2-yl)oxy]-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-16-yl acetate

2-hydroxy-3,8,8,17,19-pentamethyl-22-(prop-1-en-2-yl)-9-[(3,4,5-trihydroxyoxan-2-yl)oxy]-23,24-dioxaheptacyclo[19.2.1.0¹,¹⁸.0³,¹⁷.0⁴,¹⁴.0⁷,¹².0¹²,¹⁴]tetracosan-16-yl acetate

C37H56O10 (660.3873276)


   

(2s,5s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2e,4e,6e,8e,10e,12e,14e,16e,18e,20e)-2,6,10,15,19-pentamethyl-21-(2,6,6-trimethylcyclohex-1-en-1-yl)henicosa-2,4,6,8,10,12,14,16,18,20-decaenoate

(2s,5s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2e,4e,6e,8e,10e,12e,14e,16e,18e,20e)-2,6,10,15,19-pentamethyl-21-(2,6,6-trimethylcyclohex-1-en-1-yl)henicosa-2,4,6,8,10,12,14,16,18,20-decaenoate

C41H56O7 (660.4025826)